Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-326136
Filing Date
2026-07-30
Accepted
2026-07-30 16:13:09
Documents
92
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-20260630.htm   iXBRL 10-Q 4204442
2 EX-31.1 flgt-ex31_1.htm EX-31.1 16517
3 EX-31.2 flgt-ex31_2.htm EX-31.2 16651
4 EX-32.1 flgt-ex32_1.htm EX-32.1 19201
  Complete submission text file 0001193125-26-326136.txt   17883316

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20260630.xsd EX-101.SCH 1605901
96 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20260630_htm.xml XML 4507932
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 261223450
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)